Khiron Life Sciences Corp. (TSXV:KHRN) Director Vicente Fox Quesada was featured in an article with Benzinga. The article covered Quesada’s involvement with Khiron and what the company has been doing to become a leader in Latin America’s cannabis market. Latin America is expected to reach a valuation of $12.7 billion over the next ten years and Khiron is intent on establishing themselves as Latin America’s medical cannabis company.

Colombia and Mexico are two countries of interest in the Latin American cannabis market. Colombia’s world-renowned growing conditions and export abilities come at a low cost when compared to the lowest-cost producers in Canada and the US. Khiron is a first mover in the space and is fully licensed to cultivate, produce and distribute cannabis. The company is also able to work directly with patients and build brand awareness at clinics and pharmacies, through their partnerships with Farmatodo, Distribuciones AXA and Kuida.


As for Mexico, the country plans on legalizing cannabis in 2019.  In 2018, Khiron and Centro Fox organized the first CannaMexico Summit in Guanajuato, the home state of the former-President, to generate awareness about cannabis. Quesada has always been an advocate for the legalization of cannabis in Mexico and his involvement with Khiron will bring many advantages to the company in terms of contacts and exposure in Mexico.

To read the full article, click here.

Click here to connect with Khiron Life Sciences Corp. (TSXV:KHRN) for an Investor Presentation. 

Source: www.benzinga.com

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less